Form 4: Medtronic EVP Brett A. Wall Reports Changes in Beneficial Ownership

EVP & President of Neuroscience at Medtronic, Brett A. Wall, reports acquisition and disposal of ordinary shares and derivative securities.

Summary

• Brett A. Wall, EVP & President Neuroscience at Medtronic, filed a Form 4 detailing changes in beneficial ownership.
• On July 29, 2024, Wall acquired 14,375 ordinary shares at $0 and disposed of an unspecified amount of shares.
• Following the transaction, Wall beneficially owns 43,858 ordinary shares, which includes 573 shares acquired through dividend reinvestment.
• Wall also acquired 35,938 performance share units (PSUs) that vest on July 29, 2027.
• The number of shares issued for PSUs will vary based on performance metrics over a three-year period, potentially ranging from 0 to 71,876 shares.
• Additionally, Wall acquired options to buy 106,260 ordinary shares at $80, exercisable at 25% per year starting on the first anniversary of the grant, expiring on July 29, 2034.

Sentiment

Score: 6

Explanation: Neutral sentiment as the document primarily reports transactions. The acquisition of shares and options could be seen as slightly positive, indicating confidence, but it's a routine filing.

Positives

• Acquisition of performance share units indicates potential future compensation tied to company performance.
• Acquisition of stock options suggests confidence in the company's future stock price.

Risks

• The value of performance share units is contingent on achieving specific performance metrics, with a potential for zero payout.
• The value of stock options is dependent on the stock price exceeding the exercise price of $80.

Future Outlook

The number of shares to be issued in connection with the performance share units ('PSUs') will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 35,983 shares will be issued. If maximum performance metrics are achieved, 71,876 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and alignment with shareholder interests.

Comparison to Industry Standards

• Executive compensation packages often include a mix of salary, stock options, and performance-based equity awards.
• The vesting schedule of the performance share units (3 years) is a common practice in the industry to incentivize long-term performance.
• The exercise price of the stock options ($80) would need to be compared to the current market price of Medtronic (MDT) to assess their potential value.

Stakeholder Impact

• The transactions may influence investor perception of management's confidence in the company.
• The performance-based compensation structure aligns management's interests with those of shareholders.

Key Dates